The review gives first an introduction into the basics of surface plasmon resonance technology. The physical principle is shortly discussed followed by a discussion of the experimental details to be considered when using this technology for biomolecular interaction analysis. Based on recent publications it is demonstrated that the technology has widespread applications in many fields of the drug discovery process. Protein/protein interactions can be monitored in real time when working with biopharmaceuticals as well as protein/small analyte interactions during hit finding, secondary screening, lead optimization and lead selection. Equilibrium binding constants, kinetic rate constants and thermodynamic parameters are obtained from such study that helps to understand the mechanism of the binding reactions. This information can be directly used to improve binding properties of a drug candidate.
INTRODUCTION
Selection of promising, well characterized hits and leads is essential for success in the drug discovery process. To this end, technologies that enable a profiling of hits and leads with respect to their interaction with the targeted biological system are highly demanded in the pharmaceutical industry [1] [2] [3] . Such profiling can be performed using either functional or binding assays. In a functional assay the activity of a biological system is tested in the presence of a potential hit or lead candidate. The biological system can be a single biomolecule [4, 5] , a cascade of biomolecules including the target or a whole cellular system [6] . The term "high content screening" used for the latter indicates that this type of assay enables the extraction of comprehensive information on a complex biological system such as a whole cell [6, 7] . Especially, when signaling pathways should be influenced by new drug molecules such complex information on all proteins that are involved is needed.
Nevertheless, information on the interaction of potential drug candidates with the targeted biomolecule is important as a basis for the understanding of more complex schemes. Binding assays are the type of assays that provide such information on affinity, kinetics and thermodynamics [8, 9] . Until recently, obtaining reliable data was often difficult and time consuming, because most of the methods available used labeled compounds that had to be specially synthesized. Many of the methods were not able to follow a binding event in real time. Stop flow technologies have for a long time been the only possibility to get kinetic information on an interacting system, but this technology is time and material consuming.
HTS set-ups are preferentially used to perform functional and binding assays in order to be able to test a large number of compounds in a short time. It is well known that often a *Address correspondence to this author at the F. Hoffmann-La Roche AG, Department of Pharma Research, CH-4070 Basel, Switzerland; Tel: +41 61 688 76 17; E-mail: walter.huber@roche.com very large portion of false positive [10, 11] hits are identified for several reasons: interference with the labeling method, interaction with substrate or other auxiliary reagents, general and/or promiscuous protein binding.
Biophysical binding assays are alternative tools in generating label free, high quality data on the interaction between a target and a potential drug candidate. Label free screening methods include isothermal titration calorimetry (ITC) [12] , analytical ultracentrifugation (AUC) [13] , nuclear magnetic resonance spectroscopy [14, 15] , mass spectroscopy [16] and biosensor [17] [18] [19] .
Biosensors based on optical detection principles are the type of sensors most often used. They offer a rapid way to determine relevant binding data without the need for labeling of the interacting molecules. These biosensors measure in real time the quantity of complex formed between a molecule immobilized on the sensor surface and a molecule in solution. The optical biosensor type most often used in such experiments is based on determining small changes in refractive index induced at the interface upon binding. A huge number of different optical techniques to monitor such refractive index changes have already been introduced in the past and this number is still increasing [21] [22] [23] [24] . It is not the goal of the present review to discuss the physical principles of all of them. Surface plasmon resonance (SPR) will be discussed as the only example since it is presently by far the most widely used.
The goal of the review is to introduce to the non specialist reader to the use of the SPR technology in drug discovery and to present the opportunities it offers with a limited number of examples from the literature. When first launched, the technology was most frequently applied in the characterization of diagnostic antibodies used in immunological testing. With the growing interest in biomolecular drugs, the technique was more and more applied in the drug discovery. A few examples from the discovery of biopharmaceuticals will be presented. A real challenge, however, was to apply the technique for the discovery of low molecular weight drugs. It is only more recently that interactions of small synthetic molecules with biomolecules were described. This type of application became possible due to increased sensitivity through improvements in hardware, software and data evaluation.
The review is structured into three main parts. The first one gives a very basic introduction into the physics of the surface plasmon resonance phenomenon together with a discussion of different instrumental set-ups. A short summary on instruments available on the market is given at the end of chapter 2. Chapter 3 describes how binding experiments are performed on SPR instruments and how the relevant data are extracted. Chapter 4 gives on overview on procedures to immobilize one of the interacting partners to the SPR sensor surface. Chapter 5 summarizes work that was recently published using this technique. It is thereby outside the scope of this review to give a complete literature citation. Such surveys appear yearly in the "Journal of Molecular Recognition". These reviews show a steady increase in the number of publications per year; for instance, the survey for the year 2003 contains already 962 papers [25] .
THE SURFACE PLASMON RESONANCE BIOSEN-SOR

The Physics Behind the Surface Plasmon Resonance Phenomenon
This short introduction is thought to describe the phenomenon of surface plasmon resonance for a broad readership. The reader interested in a comprehensive and complete treatise of the topics is referred to the excellent publications of H. Raether [26] [27] . To offer the reader concrete impressions some physical properties, in particular for gold, are numerically given. Most of them were computed according to the theory of the free electron gas [28] .
The electronic properties of a material change drastically upon reducing its size and dimensions. Richard Feynman already foresees the tremendous numbers of technological applications of the small scale world in his famous talk "There's Plenty Room at the Bottom" hold at the annual meeting of the American Physical Society at the California Institute of Technology on December 29, 1959 [29] . Reducing size and dimensions the properties of a material change drastically. What is bulk and what is small? Let's have a look at the electrons. They are small. They are responsible for the chemical properties of the bulk material. Free electrons are in high concentration in metals, 8.50 •10 22 per cm 3 for copper and 5.90 •10 22 per cm 3 for gold, where they are warrant, for instance, for good electric conductibility. They are considered here like a gas. Physicists call plasma an ionized gas like the free electrons in a metal. The mean free path, i.e. the distance they can move without any collision is about 30 nm for Au at room temperature. What happens when the electron motion is more and more confined? The strongest type of electronic confined motion is the atomic confinement. In the hydrogen atom the electron is confined in a length scale of 53 pm, the so-called Bohr radius. In an infinite film of thickness of the mean free path it will prefer to move in the film plane. This means that an electric field applied parallel to the film contribute to the movement like in the bulk. An electric field applied perpendicular to the film acts however on the confined electrons. They begin to sense the surface. Let us see what happens in more details.
A displacement of the electrons perpendicular to the surface generates an electric field because of the positive charged Au-ions left behind. This field acts like a reset force on the electrons. If the external perpendicular field oscillates the electrons oscillate, giving rise to plasma oscillations. The energy quantum of plasma oscillation is called plasmon in analogy to the photon which is the energy quantum of an electromagnetic wave. At sufficient high frequencies or sufficient short wavelengths the reset force cannot follow the field. For gold the cut off or bulk plasma frequency ω P is 1.37•10 16 sec -1 , corresponding to a wavelength of 137 nm. The frequency dependence of the interaction is called dispersion. Now, the electrical field in a medium is characterized by its dielectric function ε, with the relation ε = n 2 , n being the refractive index. In particular, because ε is a measure of how strong light is absorbed by a molecule it is often called absorption coefficient or even extinction coefficient. The more general and correct designation of dielectric function is here preferred since it describes the interaction of the electric field in presence of dielectrics. At high frequencies it is convenient to deal with a complex dielectric function, i.e. a dielectric function containing a real part and an imaginary part. What does it mean? The real part means absorption whereas the imaginary part indicates dispersion and dissipation. For metals the real part of ε is negative for frequencies ω < ω P . This can be expected because the electrons following the exciting field screen it out. For instance ε = -11.82 + i1.18 [27] for gold at λ = 633 nm (HeNe laser line). This means also that no electromagnetic waves can propagate in such a medium. The waves decay exponentially. At frequencies ω > ω P the electrons cannot follow the field. The real part of the dielectric function becomes positive allowing the propagation of electromagnetic waves. In the deep UV region λ < 137 nm Au becomes transparent! Let have a still closer look. How good the field is screened out is given by the screening length. Within the screening length the electrostatic screening is practically negligible whilst outside the screening length it is increasingly efficient. At a first approximation (Thomas-Fermi) it amounts 50 pm or 0.58 Å for Au. Accordingly, the electrons in this very thin layer can be efficiently excited by an external electric field leading to plasma oscillations at the surface, not in the bulk. Note that the confinement is of the same order of magnitude as for the atomic confinement (Bohr radius).
Thus, an external electric field perpendicular to the surface can act on these electrons giving raise to surface charges waves. The energy quantum of these of surface charges oscillations is called surface plasmon (SP). The surface charge oscillations give then rise to an electric field at the boundary. How do these surface charge waves couple with the external electric field?
Referring to Fig. ( 1) a light beam, i.e. an electromagnetic wave represented by its wave vector k impinges at a thin Aufilm deposited on the surface of a glass half cylinder. The wave vector of amplitude k = ω/c or k = 2π/λ, where λ is the wavelength, points in the propagation direction of the wave which travels in a medium at the phase velocity c depending on the frequency. This is the phenomenon of dispersion already mentioned above.
The electric field of the electromagnetic wave, perpendicular to the direction of propagation, can lie in two planes, E p parallel (p-polarized light) or E s perpendicular to the incident plane (s-polarized light). E s has the field components E x and E y , which simply induce movement in the bulk whilst only E p has a field component E z perpendicular to the film surface. Thus only p-polarized light is able to excite surface plasmons (Fig. 1a) . The dispersion relation determines the conditions of the coupling.
Let call k ⊥ the wave vector of the charge oscillations. It is coupled to the external exciting wave k by the relation k 2 (Fig. 1b) . If k x < k, k ⊥ is real. The SP's emit a real electromagnetic wave or photons outside the plasma and they are called radiative. If however k x > k, k ⊥ is imaginary. This means that the intensity of the oscillations along the boundary decays exponentially, because of internal damping. It reaches 1/3 of its value after ~100 µm for excitation in the visible range. The electromagnetic field generated by the SP decays also exponentially, both outside and inside the plasma so that the SP's do not emit photons. They are called nonradiative. Both SP waves of frequency ω SP ≤ ω p /√2 are surface bounded as they represent charge oscillations in contrast to photons which represent the free electromagnetic waves. For maximal effect or resonance behavior the dispersion relation has to be fulfilled.
Here we are interested in the nonradiative SP. The nonradiative SP condition k x > k means that it is not possible to excite these oscillations by shining light directly on the film. To excite nonradiative SP the phase velocity c of the exciting light has to be reduced to equal the phase velocity of the SP waves. This can be done by the use of a prism or better by a half cylinder of refractive index n. Sandwiching the plasma, i.e. the Au-film of a thickness d between 2 media of different refractive index n 1 and n 2 (Fig. 1b) the magnitude of k x can be increased by varying θ. At the boundary n 1 /Au, k x = n 1 ⋅k⋅sinθ. If n 1 > n 2 , the critical angle θ crit for total reflection is given by the known relation sinθ crit = n 2 /n 1 . Thus from θ crit to θ = 90° k x increases from k x = n 2 ⋅k to k x = n 1 ⋅k and can fulfil the dispersion condition between the two limits for a certain k x value at the boundary Au/n 2 . Matching of the surface plasmon resonance (SPR) conditions at θ = θ SP leads to a strong charges oscillation. This is revealed by a striking decrease of the reflected light (Fig. 2) . Fig. (2) . SPR curve of a 49 nm Au-film against air recorded by scanning the incidence angle θ. The SP were excited at 633 nm with a glass half-cylinder of refractive index n 1 = 1.52. θ crit = 41.12°, θ SP = 43.58°.
Thereby the film thickness d is crucial as it determines the coupling of the SP's of both boundaries n 1 /Au and Au/n 2 . At the optimal thickness of d = 50 nm the reflected intensity could be zero, indicative of perfect resonance. Au-films with d > 150 nm show no minimum in the reflectivity and can already be considered as semi-infinite plasma. Reducing the thickness to d < 50 nm broadens the resonance curves since the SP's become more radiative as they couple back to the medium n 1 . At resonance the electromagnetic energy density Fig. (1) . Electric fields and wave vectors in the plane of incidence.
a) E p is the electric field of a p-polarized incident electromagnetic wave k i with its components E x and E z . E s shows the position of the electric field for a s-polarized light beam. It lies in the xy-plane perpendicular to the plane of the page with components Ex and Ey. k r is the reflected beam. θ i and θ r are the angles of incidence and of reflection, respectively. The boundary between the medium of refractive index n 1 and the Au infinite film is located at z = 0. b) Excitation of SP on a thin Au-film of thickness d by light. k ⊥ is the wave vector of the charges oscillations. The half-cylinder of refractive index n 1 > n 2 allows increase of k x by varying the angle of incidence θ i .
reaches its maximum at the boundary Au/n 2 . It is interesting to note that the field enhancement due to SP, i.e. the ratio of the electric field of the SP's to the incoming electric field in the medium n 1 , amounts ~40 for Au at 633 nm. Due to the imaginary part of the dielectric function the SP oscillations are strongly damped. With Au-films the intensity decreases to 1/3 of its value after a distance of 9 µm or of 6 µm if the boundary Au/n 2 of the film senses air or water, respectively. The energy is dissipated in heat. Interesting is also the spatial extension of the fields. Again for 633 nm and an Au-film it reaches 1/3 of its amplitude at 350 nm in air or at 260 nm in water. This means that the SP effectively sense changes in the refractive index at the surface and in the bulk till a distance equal to 1/3 of the exciting wavelength. SPR is extremely sensitive to the ratio n 1 /n 2 . For a fixed exciting wavelength increasing n 2 shifts θ SP to increasing values. For fixed n 2 the behaviour of the reflectivity curve depends on the wavelength. Higher wavelength, for instance 850 nm, leads to narrower resonance curve and lower resonance angle than shorter wavelength, for instance 630 nm.
Instrumental Set-Ups to Perform SPR Measurements
As we have seen before SP cannot be directly excited by light but need a device able to slow down the light propagation in order to allow matching to the surface plasmon oscillations. Basically there are 2 kinds of methods, the attenuated total reflection or ATR coupler and the grating coupler.
The ATR coupler in the arrangement proposed by Kretschmann [30] is depicted in Fig. (3) and makes use of the ATR coupler. The p-polarized light beam, often from a laser, is a directed to a half cylinder coated with the gold film and a photodiode detects the reflected light. In first laboratory set-ups light source and detector were move mechanically solidly united to preserve angle of incidence equal angle of reflection. Performing an angle scan the detector records a reflected light profile as shown on Fig. (2) . Alternatively the incident light can be slowed down by a diffraction grating (as shown by Raether, [26] ). The light beam incident on the grating, with its grooves perpendicular to the incident plane, is diffracted and the k x component of the incident wave vector k parallel to the interface is increased due to the pitch of the grating.
There are other sophisticated configurations like optical waveguide systems but all of them make use either of the ATR or of the grating coupler or of a combination of both.
The detector (Fig. 3) can record the reflected light as a function of the incident angle or as a function of the wavelength. Changes in the refractive index of the medium 2 shift the angle of the resonance for a fixed wavelength or, conversely, shift the resonance wavelength for a fixed angle of incidence. What are the differences in sensitivity between grating and prism couplers? For angular detection, sensors using prism and grating couplers exhibit comparable sensitivity. For wavelength detection, the sensitivity provided by the prism coupler is much better than the grating counterpart [31] .
Modern instrumentation contains no moving part. Light coming from a lens makes all incident angles available at once. Reflected light is detected by diode arrays. Light sources like light emitting diode (LED) or laser diode in the typical wavelength domain ranging from 700 nm to 900 nm are cheap. The analyte solution contacts the SPR sensor through a microfluidics system. Au prevails in SPR sensors because of chemical and physical reasons. On the other hand Au has a higher sensitivity in the above mentioned wavelength domain than Ag, for instance, because the absolute value of the real part of its dielectric constant is smaller than that of Ag, |ε r  Au < |ε r  Ag [31] .
Instruments on the Market
Since the first launch of an SPR system by Biacore AB a number of commercial SPR biosensor systems have become available [17] [18] [19] [20] 25] . The Biacore system still dominates the market. The most recent systems introduced are the Flexchip system mainly applicable for fast screening of proteinprotein interactions, the Biacore T100 system for the detailed characterization of biopharmaceuticals and quality control, the S51 system especially suited for interaction analysis with small molecules and the A100 system with an increased capacity to characterize compounds against a broad panel of immobilized interactants or increased capacity for screening larger numbers of compounds against a small number of interactants. The company offers not only instruments but also a broad panel of sensor chips with different surface chemistry for various applications. The SPR principle is also exploited by several other competing companies [25] such as Texas Instruments, Nippon Laser Electronics and DKK-TOA. Because of the large numbers of users applying Biacore systems the review is focused on experiments using these instruments. As mentioned already in the introduction, there exists a similar experimental set up that makes use of dielectric planar waveguides instead of gold layers [20] [21] [22] [23] [24] . Most of the points emphasized in this article concerning immobilization, binding experiments and data evaluation can be applied to all of these technologies.
THE SPR BASED INTERACTION ANALYSIS
How to Perform a Binding Experiment Using SPR
With a direct binding assay format the interaction between a ligand and an analyte is investigated. The terms ligand and analyte are usually applied to the interacting molecule immobilized on the sensor surface and the molecule dissolved in the test solution, respectively. Sometimes the term receptor is also used for the immobilized molecule. This nomenclature will be used throughout this review article.
For a binding experiment the ligand has to be immobilized in a first step on the sensor surface. Different immobilization methods will be discussed in chapter 4. It is highly recommended to monitor the amount of immobilized ligand because this is valuable information for the analysis of the analyte binding.
At the beginning of a binding experiment the surface with the immobilized ligand is in contact with a running buffer and the measured response corresponds to the baseline level. During the so called contact or association phase this buffer is exchanged by the analyte solution. To avoid background signals due to changing buffer conditions running and analyte buffer composition are kept identical as much as possible. At the end of the association phase the analyte solution is again exchanged by running buffer. The following time interval is called the dissociation phase indicating that for a reversible binding event the analyte should dissociate from the immobilized ligand during this time period and the signal return towards the baseline.
The time dependent sensor response monitored during the binding experiment is called a sensorgram (see Fig. 4 ). During a binding event an increase in sensor response is observed during the contact or association phase. The increasing response approaches finally a plateau value which corresponds either to the equilibrium sensor response or above saturation concentration it represents the saturation response.
If binding experiments are performed with very sticky analyte molecules, the injection systems are often contaminated by the analyte. Subsequent binding experiments are then influenced by carry over effects. They can be suppressed by including a system washing phase during which the injection system but not the immobilized surfaces are washed. Absence of a carry over effect can be proven by injecting analyte free buffer solutions.
The surface plasmon measurement is also very sensitive to small refractive index changes in the bulk solution. Since small mismatches between running buffer and analyte solutions can normally not be avoided, the experiment is normally performed in parallel on reference channel. The reference signal can then be subtracted from the signal measured in the active channel. If high sensitivity is required more sophisticated referencing is normally required [32] .
Data Analysis
The binding responses recorded using surface plasmon resonance technique can provide an enormous amount of information. A visual inspection of the response curves monitored for different analyte concentrations (see Fig. 4 and Fig. 6) indicates if a) complex formation takes place (increase of response during association phase), b) reaches equilibrium and/or saturation (plateau value of response at the end of association phase) and c) is reversible (steady decrease of response). It also gives at least qualitative information on the kinetic stability of the complex formed (fast or slow approach to baseline line level during the dissociation phase). Applying more sophisticated, quantitative analysis of time and concentration dependent response curves provides quantitative information on the stoichiometry of binding, equilibrium binding constants, kinetic rate constants and the mechanism of complex formation. Moreover, temperature dependent measurements can provide the thermodynamic data of complex formation. The methods to extract such information from sensorgrams and the way to gain information about specificity will be discussed in the following.
Stoichiometry of Binding
The number of analyte molecules (N) bound to an immobilized ligand is an important parameter when characterizing an interaction. This number is not directly available from a single binding experiment. It can semiquantitatively be determined by considering information from the immobilization experiment or by considering results from binding ex- periments with a reference analyte with known binding characteristics.
An estimation of the numbers of analyte molecules binding per protein (N) is based on the following equation.
The equation contains parameters that can be easily assessed, such as the molecular weight of the ligand (MW ligand ) and the analyte (MW analyte ) as well as the responses measured after the immobilization of the ligand (R ligand ) and after contacting with analyte (R analyte ). Both the refractive index increments of the analyte ((δn/δC) analyte ) and the ligand ((δn/δC) ligand ) as well as the fraction of ligand that is active after immobilization (P) are more difficult to quantify. Since values for P as low as 0.2 (20% activity) have been reported, applying the equation without a correction for the reduced activity could lead to severe errors in the estimation of the number of bound analyte molecules. Uncertainties linked to this assumption can be eliminated by using reference analytes with known stoichiometry. The determination of the saturation response (R reference, sat.) with this compound can be used either to estimate the fraction of active protein (P) or be used to estimate the number of bound molecules leading to a modification of the above expression.
In this equation both refractive index increments remain the only unknown parameters. The refractive index increment is a measure for the change in refractive index caused by a change in the concentration of bound analyte or ligand in mass per volume. Often it is assumed that these refractive index increments are nearly constant for ligand and analyte series. A recent publication reports on the determination of such increments via concentration dependent refractive index measurements [33] . The results stress the importance of accounting for these increments when determining exact stoichiometry.
Specificity of Binding
Since any adsorption of an analyte to the surface leads to a positive response in a SPR experiment, the technology is not able to directly differentiate if binding occurs at the desired binding site of the target protein, or at any place on its surface or even anywhere on the surface of the sensor. All these processes lead to a positive response during the association phase and will influence the determination of binding constants and characterization of the binding behavior. Special effort is required to design an experimental setup that can distinguish clearly between specific and unspecific binding. Most of the approaches are based on preparing reference channels by immobilizing proteins that are structurally closely related to the target but show no specific binding to reference analytes. Another possibility is to perform competition experiments with compounds that bind to the binding site.
Fig. (5).
Binding pattern for a substrate analogue of bacterial aldolase. Mutation of Glu74 to aspartate leads to a protein that does no longer bind the substrate analogue.
Ideal proteins to be used as a reference are proteins that can be obtained by site directed mutagenesis, i.e. by impairing or modifying the targeted site of a given protein via the exchange of one or several essential amino acids [34] . Such a modification changes very locally but efficiently the binding behavior of compounds to the targeted site without modifying unspecific binding. Two examples are given [34] . The proteins, aldolase and HPPK, are enzymes of the folate pathway and are targets in the development of new antibiotics. In the case of aldolase, the binding site was successfully disturbed by exchanging glu74 by arg (see Fig. 5 ). This amino acid reduces the free space in the active site of the aldolase and, even more important, turns a negative charge into a positive one. The slight modification was sufficient to inhibit binding of substrate like compounds that were used as reference compounds during hit finding process. In the case of HPPK, replacing asn56 with ala was also sufficient to destroy completely the binding activity to substrate-like compounds.
Another possibility for preparing an ideal reference channel is to block the target site on the protein with a covalent inhibitor. For instance, inhibitors that form selectively covalent bonds with the activated serine in serine proteases are well known in the literature. We used this approach [34, 35] for instance in case of DPP-IV (dipeptidylpeptidase IV) a target in the treatment of diabetes II (see Fig. 6 ). In this case blocking could be performed directly on the immobilized protein avoiding working up procedures after blocking. An alternative approach to proof specific binding is to perform competitive binding assays with a reference compound that binds specifically to the target site [36, 37] . In this case the binding experiments have to be performed with pure test analyte solution, with the reference compound solution and with mixtures of both. Generally, the compound concentrations in mixtures are the same as those in the solutions that contain analyte and reference alone. In case of noncompetitive binding (different binding sites) the sensor signal that results from the mixtures is simply the sum of the sensor signals that were measured in contact with the solutions that contain the two compounds alone. In case of competitive binding the resulting signal of the mixture is intermediate between the two signals measured for the solutions containing one of the compounds alone. If the competitor is added at saturation concentration the signal of the mixture corresponds to the signal observed for the competitor solution. The signal that can be expected for the mixture can be estimated by calculating the fractional occupancies of the binding site by competitor and test analyte with the following equations below. They can be derived by applying the law off mass action under the assumption that the concentration of the compounds in solution is not changed upon binding (this assumption is only applicable when working with a flow system). (4) Recently it has been shown that competition becomes also obvious from the kinetics of the mixtures if the competitor and the analyte have different kinetic behavior [37] .
ATP was used to compete with the binding of a p38 inhibitor. With increasing ATP concentration the slow kinetics of the inhibitor turned into the fast kinetics of ATP indicating clearly that the inhibitor became replaced by ATP.
Affinity Constants from Equilibrium Analysis
The interaction of an immobilized ligand molecule (L) with the analyte molecule in solution (A) can be written in the simplest case as
The fraction of occupied binding sites on the surface at equilibrium (θ eq ) with a given free analyte concentration [A] in solution can be expressed by the equation for a Langmuir adsorption isotherm.
Therein, K D represents the dissociation equilibrium binding constant and [A] the concentration of the free analyte in solution, which is a constant when working with a continuous flow of analyte solution. θ eq , the fraction of occupied binding sites, is directly proportional to the ratio of the equilibrium sensor response (R eq ) monitored at a given ligand concentration and the maximum response monitored at saturation (R sat ), i.e. at full occupancy of all binding sites. A plot of θ eq versus the concentration asymptotically approaches unity (Fig. 7) . A fit of this plot using the equation for a Langmuir isotherm leads to the equilibrium binding constant K D .
Such equilibrium sensor responses can, however also be exploited by a Scatchard type analysis. In this case, the equilibrium sensor response, which is proportional to the number of bound analyte molecules, is plotted against the ratio of sensor response and concentration (ratio of bound and free analyte). i.e. each binding site is occupied by one single analyte and each binding site exhibits an identical affinity that is independent from the number of occupied sites. Deviation from ideal behavior might origin mainly from the random immobilization of the ligand influencing the accessibility of binding sites, from affinity altered by the linker, from the steric hindrance with increasing occupancy in case of high density of binding sites or from ligand molecules possessing several binding sites of different affinity. Deviation from ideal behavior is indicated by the shape of the adsorption isotherm or deviation of the Scatchard plot from linearity.
Application of the above equation for the isotherm is valid only for systems exhibiting ideal Langmuir behavior,
From an experimental point of view it is important that the response during the association phase reaches a steady state. Often this is only the case for low affinity systems for which the association reaction is fast because of the high working concentration needed. In fact, for these systems this kind of analysis is often the only way to get information on the binding affinity. Kinetic analysis as described in the following chapter is often not possible because the time course of the reaction can not be properly resolved. Fig. (8) shows a typical example of this kind. It concerns the interaction of a tri-peptide (ile-pro-ile) with DPP IV immobilized on an SPR sensor [35] .
Determination of Interaction Kinetic Parameters
Because the working concentration of the analyte in solution has to be kept around the equilibrium binding constant K D (0.1⋅K D < C < 10⋅K D ) equilibrium responses are only achieved after long time intervals when working with high affinity system. At low concentrations the process is slowed down because the velocity of this process is the product of the association rate (k on ) and the free analyte concentration. A typical example of this kind is depicted in Fig. (9) . The figure shows binding of a small inhibitor to immobilized DPP IV [34] . 
Fig. (8).
Binding of a tri-peptide (ile-pro-ile) with an affinity in the micro-molar range monitored using SPR technology. Measurements are performed on a Biacore 3000 instrument.
Fig. (9).
Binding curves for the binding of a small molecular weight inhibitor monitored using SPR technology (Biacore S51 instrument). The smooth black curves are the result of the fitting procedure. The curves were fitted using a kinetic model for the formation of a 1/1 complex. The residuals of the fit are graphically depicted below the binding curves. Significant deviations are observed between experiment and fit when only considering binding kinetics. They can be drastically reduced (bottom) when including into the model the effects of mass transport limitations [38] .
The affinity of the compound is in the sub -nanomolar range and experiments have to be performed in this concentration range. At highest concentration the curves approach equilibrium. The curves monitored for lower concentrations still show an increase that indicates non-equilibrium situation. Such curves are not suitable for an equilibrium analysis. However, they are ideal for a kinetic analysis which offers access to the association and dissociation rates and the K D that represents the ratio of the two kinetic rate constants. The simplest kinetic model that can be applied to such curves is that of the formation of a 1/1 complex.
and the dissociation rate by
[LA] is the number of occupied binding sites which is directly related to the relative sensor signal (difference between response before injection of the analyte solution and the signal after a certain time interval t of contact with the analyte solution). d[LA]/dt is nothing else than the measured time dependent sensor response.
[A] is the concentration of the analyte in solution and is a constant for a system with a continuous flow. [L] is the concentration of the free binding sites on the sensor surface and is given by the difference of the total and the occupied number of binding sites. Using numerical fit procedures the experimentally monitored time dependent association and dissociation curves can be fitted to the above given time laws. Main fit parameters are the association and dissociation constants k on and k off . The experimental curves depicted in Fig. (9) are overlaid by curves resulting from such a fit. Two models are applied to the experimental curves; formation of a 1/1 complex with and without considering mass transport limitation. A much better overlap with the experimental curves is obtained by considering mass transport limitation. In this example mass transport from the bulk into the binding matrix has to be considered to get out accurate kinetic data from the fit.
Curve fitting can be applied in principle to every kinetic model. In general such fit programs are delivered by the instrument manufacturers or can be obtained from the internet. Before applying more complex kinetic models one should clearly establish by additional experiments that the complex kinetics does not result from experimental artifacts [39] [40] [41] [42] [43] The value of kinetic information for drug discovery has been underestimated for a long time. This is in part due to the fact that the determination of such data for a large set of compounds has only become possible since the introduction of technologies such as SPR that enable real time monitoring of binding events without consumption of large amounts of material. The one dimensional ranking of compounds by equilibrium binding constants receives an additional dimension by including on-and off-rates. This becomes most obvious when representing all the data in so called k on / k off plots (Fig. 10) .
In such graphs the logarithm of the on-and off-rates are plotted along the x-and y-axes. Compounds that have an identical ratio between on and off-rates, i.e. compounds with an identical equilibrium binding constant, derived from different kinetics, are located not at the same place in such a graph but are located along diagonal lines. Breaking down equilibrium data into the underlying kinetic data can improve the resolution of the compound ranking and support the selection of the most promising compounds. Since such onand off-rates differ by several orders of magnitudes the difference in kinetics can be also of biological relevance, for instance a difference in off-rates of three orders of magnitudes corresponds to a difference in the half-life time of the complex of several hours. In view of this, it should no longer be of any surprise that compounds having identical or similar K D -values can behave totally differently in the biological system.
Determination of Thermodynamic Parameters
The change in free energy (∆G) upon formation of the analyte-ligand complex can be calculated directly from the equilibrium binding constant K D . Other thermodynamic parameters like enthalpy (∆H) and entropy (∆S) are not directly available from binding curves. Two different methods can be used to get access to such parameters. Both make use of the temperature dependence of equilibrium binding constant K D [44] .
In the simplest analysis, ∆H and ∆S are assumed temperature independent and can be obtained from a plot of lnK D vs 1/T. ∆H and ∆S can, however, sometimes have significant temperature dependences, although van't Hoff plots appear linear with correlation factors of 0.95 or higher. It is therefore not surprising that application of the linear van't Hoff plot can lead to thermodynamic parameters that substantially deviate from those determined by calorimetry [45] . The temperature dependence can however be taken into account by introducing a temperature independent heat capacity (∆C p ) and applying the integrated form of the van't Hoff equation [44, 46] . Since the temperature range is generally limited for proteins this approach needs high quality experimental data.
Based on the temperature dependent kinetic rate constants k on and k off a thermodynamic analysis of the transition state has been performed by employing the Eyring theory [44] . Entropies and enthalpies of formation of the transition state (∆H Finally, it must be stressed that biosensors measure only complex formation in time, compared with calorimetry, which directly measures enthalpy of the reaction. van't Hoffs enthalpy change will equal the calorimetric enthalpy change only if the binding follows a two state transition between free and bound molecules. Systematic differences in the van't Hoff and calorimetric enthalpies may indicate that the reaction involves multiple states or major conformational changes. A comparison of these enthalpies thus provides complementary information. In the case of limited amounts of material for calorimetric studies SPR results might be useful in providing some insight into the reaction thermodynamics.
Critical Issues in Data Analysis
A lot of work has been published dealing with the reliability of equilibrium, kinetic and thermodynamic parameters extracted from SPR experiments, because such parameters could be influenced by the fact that the proteins are immobilized. Therefore, parameters obtained via SPR were compared with parameters determined from experiments that were performed in homogeneous solutions using for instance fluorescence or calorimetry as the detection methods [45] [46] [47] . Inconsistent reports ranging from full correspondence of data to also large disparities were demonstrated during such studies. Consequently, different conclusions emerged and it is sometimes difficult to decide which of the methods under comparison suffers more or less from artifacts.
Systematic errors in estimating rate constants are most often discussed in relation to the transport of analyte, which could be hindered when using three dimensional binding matrices to increase density of ligands. In such cases two possible sources for the breakdown of the rapid mixing model exist [43] . This model treats the transport of analyte in two steps: 1) the transport (diffusion and flow) of analyte to the outer interface of the matrix and 2) the transport (mainly diffusion) of analyte into the matrix layer. It has been demonstrated by several authors that under appropriate experimental conditions (i.e. low binding capacity at the surface) the three dimensional layer has no significant influence on the binding kinetics. To consider the bulk transport effects on the SPR signal a model can be used that treats binding as a two-step model: transport of analyte to the sensor surface, followed by the reaction of the analyte with ligands on the surface. It is demonstrated that this model can be used to determine accurate values of the rate constants. The model is incorporated into the analysis software by the instrument manufacturers. Simple tests for self consistency have been suggested in this respect to assess the validity of kinetic biosensor data [48] .
Recently a broad study was induced to demonstrate the lab-to-lab reproducibility of such measurements [49] . Acetazolamide (222 Da) binding to carbonic anhydrase (30 kDa) was used as the model system. A total of 36 different investigators determined on-and off-rates as well as K D values for this system. A 1/1 interaction model that included a term for mass transport was used to globally fit the time dependent binding curves. Although a broad variability was observed during the immobilization step only a small variability was found for the kinetic parameters. The average association and dissociation rate constants were 3.1±1.6⋅10
6 M -1 ⋅s -1 and 6.7±2.5⋅10 -2 s -1 , respectively. The corresponding dissociation equilibrium constant was 2.6±1.4⋅10 -6 M. The result clearly indicates the robustness and the lab-to-lab reproducibility of the method to determine kinetic parameters.
IMMOBILIZATION STRATEGIES
The interface between the sensor surface and the chemical or biological systems to be studied is a key component of SPR biosensors. The receptor molecule must be immobilized on the surface while retaining natural folding and binding activity. Sufficient binding sites should be generated by the immobilization and the attachment should be sufficiently stable over the course of a binding reaction. In addition, the interface formed should be resistant to non-specific binding.
There are different approaches to solve the problem of adequate immobilization. All of them are based on the formation of an organic adlayer on the gold surface. The most straightforward way is based on the use of functionalized alkane-thiols that form self-assembled monolayers on gold [50, 51] that can be chemically modified [52, 53] in situ. The thickness of this adlayer can range from thin monolayers of about 1-2 nm thickness up to organic adlayers of 100 nm thickness. The decision about which type to be used might depend on both the application and on the nature of the ligand. A soluble protein, for example, definitely needs a different supporting layer than a membrane protein. If the interaction with a large biomolecule is studied immobilization on a two dimensional adlayer might be preferred because the large molecule needs to be prevented from diffusing into the adlayer during binding, so that binding kinetics will be less influenced by mass transport limitations. Monitoring the binding of a small molecule needs a high density of active binding sites, which can generally only be achieved by using a thick organic adlayer that enables the immobilization of several monolayers of protein.
Two main strategies can be used to attach ligands to the organic adlayers. Covalent coupling leads to stable, regeneration resistant receptor layers. However, not all biomolecules can withstand the relatively harsh conditions that are normally needed for efficient coupling. Stability during immobilization is normally not a problem when immobilizing a small synthetic molecule instead of the large biomolecule. However, the problem of coupling a small synthetic ligand to a surface without influencing its interaction with the biomolecule should not be underestimated and possible artefacts due to such a coupling must be excluded experimentally.
The second alternative type of linkage, capture via an affinity tag, leads to ligand layers of higher relative binding activity. However, the total amount of protein that can be immobilized is less and the kinetic stability of the taginteraction is often not sufficient to exclude baseline drifts due to the dissociation of the ligand. Dissociation of the captured ligand can be avoided by a subsequent crosslinking step, although this stability may have to be paid for by a reduction in binding affinity. If the attachment needs a tagrecognizing protein on the surface one has to keep attention on an interaction of the analyte with this protein. Independent testing of the binding of the analyte to this protein is therefore crucial.
Covalent Immobilization of Soluble Ligands
Amine coupling is the most prominent and most often used method to attach a protein covalently to an organic adlayer. The coupling chemistry requires free carboxylic acid groups on the surface that most often are transformed into reactive N-hydroxysuccinimide esters by treatment with carbodiimide and N-hydroxysuccinimide. Coupling occurs mainly with free amino groups of lysines. Efficient coupling with low amounts of protein is possible when exploiting the coulomb interaction of non-activated carboxylic acid groups on the surface and a positively charged protein in solution [53] . This is only possible when the protein can be stored for the time period of immobilization in buffers of low salt concentration and a pH between the isoelectric point of the protein and pK of the acidic groups on the surface. The coupling leads to random orientation of the ligands on the surface and consequently to a heterogeneous population. Coupling via lysines located in the active site leads to deactivation of the ligand molecule.
Thiol coupling can help to immobilize the protein in a more defined orientation since there are often fewer potential sides for coupling on the surface than with amine coupling. It can also be used if the receptor is inactivated during immobilization because of a reactive amine group in the ligand binding site. Thiol coupling is often used when coupling acidic proteins (isoelectric point < 3.5) which are difficult to be immobilized by amide coupling. Coupling is achieved either via derivatization of the sensor surface with sulphydryl-reactive reagents (for instance pyridinyldithioethanamine (PDEA)) that then react with free thiols from cysteines and methionines at the surface of the protein or alternatively by modifying free thiol groups on the surface of the protein with sulfhydryl reactive reagents.
Aldehyde coupling enables a more oriented immobilization because such groups are located mainly in the carbohydrate residues of biomolecular ligands. The aldehydes could be native to the receptor protein or could be introduced by oxidation of cis-diols that are present. This coupling requires transformation of surface carboxylic acids into hydrazides followed by reductive amination.
A biochemical coupling method was recently introduced that made use of a fusion protein containing the ligand to be immobilized and human-O 6 -alkylguanine-DNA-alkyltransferase (h-AGT) [54, 55] . The latter could be fused to the ligand either via its N-or the C-terminal end. h-AGT is a DNA repair protein that irreversibly transfers an alkyl residue at a guanine to its active site. The enzyme is very tolerant to structural variation of the substrate. It was demonstrated that immobilization of the alkylguanine derivates on a sensor surface enables covalent coupling of a h-AGT containing fusion protein to the surface. The activity of the immobilized receptor was very high (close to 100%) due to the non random immobilization. Moreover, h-AGT fusion proteins could be immobilized without purification directly from crude cell extract.
Immobilization of Soluble Receptor via Affinity Tags
The biotin streptavidin interaction with its high affinity (K D ≈ 10 -15 M) and extremely slow dissociation rate has been exploited by researchers for the immobilization of proteins to surfaces. Usually protein biotinylation is performed, whereby lysine residues of the target protein are modified by chemical agents such as biotinyl-N-hydroxysuccinimide ester. However such an in vitro biotinylation suffers from the same disadvantage as covalent chemical coupling of the protein, since both result in non-oriented attachment of the protein to the surface. Recently plasmid expression systems for in vivo biotinylation were introduced that enable site directed biotinylation. It was demonstrated that such biotinylated proteins bind to streptavidin modified SPR sensor surfaces [56] .
Metal chelating is often used in the purification of proteins and Ni-chelation by surface-bound iminodiacetic acid (IDA) and nitrilotriacetic acid (NTA) have been widely used with 6xHis-and 10xHis-tagged receptor proteins. The moderate stability of such Ni-chelates which is a desired property in affinity chromatography, often leads to considerable dissociation of the protein from the sensor surfaces and hence to considerable baseline drifts. Crosslinking of the affinity captured proteins with amine coupling reagent has been suggested. More stable baselines can be obtained with this procedure but at the expense of activity loss.
Monoclonal antibodies can be covalently attached to the surface either via amine coupling or via aldehyde coupling. Epitope-tagged fusion proteins can then be directly and reversibly coupled to the surface through antibody-antigen binding. Frequently used tags are for example glutathion-Stransferase (GST), FLAG epitope or 6xHis. Also for these types of affinity tags, crosslinking is recommended when the kinetic stability of the antibody-target complex is not sufficiently high.
Immobilization of Membrane Proteins
Almost half of the 100 best selling drugs on the market are targeted to membrane receptors, creating a need to better understand the mechanism by which they bind to their interaction partner. Since such interactions are surface related processes that are difficult to study in solution, surface plasmon resonance seems to be an ideal tool. Anchoring membrane bound proteins on the planar surface of a sensor requires the prior immobilization of an artificial membrane mimetic which is able to at least roughly simulate the function of a natural membrane. Functional reconstitution of membrane proteins on solid supports for biosensor applications has been studied for many years and there are now different methods described in the literature.
The simplest method to immobilize a membrane protein on a surface is to adsorb the protein and lipids directly on a hydrophobic surface. Surfaces can be produced by directly coupling alkanes to the gold surface through a thiol group. This method is generally limited to receptors that are anchored only in the outer leaflet of the native membrane. Nevertheless, the use of this type of membrane system allowed for instance the study of the binding of the blood coagulation factor VIII [57] and antibacterial peptides [58] to membranes, the interaction of protein kinase with phospholipids [59] , the binding of lectin [60] and choleratoxin [52, 61] to glycolipid systems and the interaction of fibrinogen with glycoprotein IIb-IIIa [62] .
A lipid layer which is directly adsorbed to the hydrophobic surface is not suitable for the immobilization of a transmembrane protein with sizable cytosolic and extracellular domains. By introducing an aqueous compartment between the lipid bilayer and the solid support this limitation can be overcome. Several strategies for the formation of such supported lipid bilayers have been pursued. The lipid membrane was spiked for instance with phospholipids containing a biotinylated or an alkanethiol headgroup. Biotin-containing phospholipids were coupled to covalently immobilized avidin whereas thiol spacer-containing phospholipids were directly coupled to the gold surface forming the bilayer by a self assembling process. Both approaches enabled the functional reconstitution of membrane proteins.
It was recognized that the surface roughness of most solid materials used prevents the undisturbed organization of lipid layers [63] . These could be overcome by bridging the aqueous compartment between the solid support and lipid layer by a flexible, hydrogel polymer (either carboxymethyldextran or disulfide-functionalized amphipatic copolymers). This soft polymer cushion provides a hydrated lubricating layer between the surface and the membrane that allows self sealing of surface defects. Such model membranes were used for efficient functional reconstitution of membrane fragments and detergent-solubilized GPCR's on the sensor surface [63] . For all these immobilization strategies, the density of active protein obtained is relatively low. The surfaces are in general suitable to measure the interaction with large analytes. However, an interaction with small molecular weight compounds (MW < 1 kDa) could not be investigated so far.
An alternative approach to solve the problem has been introduced recently by Navratilova et.al. [64] . They used receptors (CXCR4 and CCR5) that were engineered with a tag called C9 that is recognized by an antibody 1D4. The tagged receptors were solubilized and captured by the antibody immobilized on a dextran modified sensor surface. The autosampler within a Biacore instrument was applied for screening receptor activity and stability using a panel of con-formation-sensitive antibodies. The set up was used to demonstrate CD4-dependent binding of gp120 to solubilized CCR5. It has recently been reported [65] for the first time that this set up was also suitable to monitor binding of molecules in the range of 500 Da.
APPLICATIONS
Biopharmaceuticals
Experimental Considerations
Sensitivity is generally not a major issue when working with biomolecules as potential drugs, because the SPR signal directly scales with the molecular weight of the molecule that binds to the surface. Therefore, immobilization of sufficient amounts of the active ligand can be achieved in most of the cases. It is even recommended to immobilize as low amounts as possible to avoid problems with steric hindrance. Capturing methods that support an exposition of the recognition site into the solution are recommended, in order to reduce artefacts arising from the interaction with the surface. A main source of erroneous results, however, is that preparations of some biomolecules often tend to form aggregates. A careful characterization by analytical ultracentrifugation or light scattering could help to exclude such erroneous results.
Monoclonal Antibody Screening and Characterization
Some of the earliest applications of SPR biosensors were as immunosensors to characterize antibody activity and to map binding epitopes. While the use of biosensors has expanded into other application areas, antibody characterization remains one of the major areas. It is now well accepted that the technology has a number of advantages over traditional immunoassays such as ELISA or RIA. The possibility to monitor the binding in real time provides more detailed information about reaction kinetics, affinity and epitope maps. Especially kinetic information can help to select from a panel of antibodies with similar affinity those which possess the ideal kinetic behaviour for a given application. The technology is so matured in the field of antibody characterization that instruments designed for GLP/GMP regulated areas of antibody development and manufacturing are already on the market. Moreover the technology has been successfully applied to screen antibodies in crude preparations such as hybridoma supernatants and in body fluids.
Monoclonal antibodies continue to be the most important biomolecular agents for therapeutics. Advanced antibody production technology [66, 67] makes it possible to create large batches of antibodies, thereby creating a bottleneck in characterizing antibody binding activity. SPR has the potential to improve the pace of antibody characterization [68] [69] [70] [71] .
The following example underlines this value of the SPR technology in the early phase of development especially through antibody selection but also stresses the value of having not only equilibrium binding data but also kinetic information. The project aimed in finding and improving antibodies against β-amyloid plaques using the phage display technology of Morphosys. Fig. (11) depicts sensorgrams of Fab fragments of a clone that was matured in two different maturation cycles and a so called crosscloning experiment during which heavy and light chains of an antibody were exchanged. The clone that was first identified by a random screen originally produced antibodies of very weak affinity. It is not unusual to find such weak antibodies in a first run. It   Fig. (11) . Improvment of antibody kinetics and affinity and during antibody maturation monitored using SPR technology. The antigen (β-amyloid fibres) was covalently immobilized on the sensor surface. Analyte solutions (Fab fragments for A, B, C, D and E, full antibody for F) were passed over the immobilized fibres .Curve A: parent clone (~200 nM). Curve B: clone after first maturation cycle (22 nM). Curve C & D: Clones after the second maturation cycle having totally different kinetic behavior but similar affinity (12.2 nM, 12.8 nM). Curve E: Clone produced by crosscloning clones from curve C and D (1.8 nM). Curve F: antibody produced from clone of curve E (0.14 nM).
would, however, have been impossible to find this Fab fragment using conventional ELISA technology. Because of the low affinity and especially because of the fast off rate this Fab fragment would have been lost during washing procedures. It is clearly obvious from both the amplitude of the signal and the dissociation profile that the affinity of the Fab fragments and the kinetics was continuously improved during the first two maturation cycle. The two Fab fragments selected from the second maturation cycle had similar affinity but clearly different kinetic behavior. One of them showed fast on but also fast off kinetics, while the other one showed slow on and slow off kinetics. An ideal Fab of higher affinity should have combined fast on kinetics with slow off kinetics. It is shown in the Figure that the two desired properties could be obtained by a so called cross cloning experiment during which heavy and light chains of the two clones were exchanged. The resulting Fab possessed a nanomolar affinity.
A recent publication by Canziani [72] has reported on the development of experimental and data analysis protocols to screen antibodies directly from hybridoma culture supernatants. The protocol includes capturing the monoclonal antibodies from hybridoma cells with an Fc-specific antihuman IgG and contacting these captured antibodies after-wards with the antigen of interest. The first step enables to quantification of the amount of antibody expressed in hybridomas and the second one enables characterizing the captured antibody with respect to its affinity for the antigen. This setup, with the bivalent antibody on the surface avoids avidity effects, which can lead to misinterpretations of antibody/antigen binding kinetics. The protocol was robust allowing over 100 capture and regeneration cycles to be performed on a single sensor chip surface. Unspecific binding from the supernatant was minimized by adding BSA and soluble carboxydextran to the samples. The protocol could be used to characterize antigen binding kinetics to ~ 200 antibody supernatants per day. The need for screening larger numbers of antibodies is obviously growing, however, which may be facilitated by two recently introduced array-format systems. Biacore A100 enables early kinetic screening of around 800 antibodies per 24 hours direct from hybridoma samples, as well as providing high resolution kinetic characterization of selected candidates. The Flexchip system uses externally spotted protein chips [73] and grating coupler surface plasmon resonance detection to provide profiling of up to 400 protein-protein interactions simultaneaousely. This enables ranking of large numbers of antibodies based on their kinetic behavior to be carried out in a single experiment.
Antibodies have carbohydrate chains (glycosylation) attached covalently to their polypeptide backbone. This posttranslational modification takes place in the endoplasmic reticulum and Golgi apparatus, and is very sensitive to many environmental parameters. Because changes in the glycosylation pattern can affect biologically important parameters such as activity, stability, solubility and biological half-life, there is an increasing interest in determining glycosylation pattern. Lectins are very useful for studying glycosylation. In combination with SPR this method had shown to be sometimes superior over conventional ELISA technology [74] . In this application the antibody was immobilized on the sensor chips and different lectins were passed over and the glycosylation pattern could be derived from the binding behavior observed for the different lectins.
Characterization of Post-Modified Biomolecular Drugs
Pegylation is one of the most prominent artificial postmodifications of biomolecular drug molecules. It can improve solubility, temperature and stability against enzymatic degradations, serum half-life, immunogenicity and thus biological effectiveness when compared with the unmodified protein. Detailed structural and biophysical characterization of the modified biomolecule is crucial for the understanding of in vitro and in vivo biophysical studies as demonstrated by a recent study on pegylated INFα [75] . This includes a thorough characterization of the biologically relevant interactions.
In the work cited above, this characterization was successfully performed using SPR technology. A detailed kinetic and thermodynamic analysis of the binding of pegylated interferon-α2 to the extracellular domain of the receptor IFNAR2 was performed. A correlation between structural parameters and the kinetic and thermodynamic results could be established that was helpful for the interpretation of biological results.
Characterization of Immune Response
The steadily increasing role of biopharmaceuticals in medicine has placed growing importance on the ability to characterize immune response during preclinical trials. Protein interaction analysis using SPR biosensors has increasingly demonstrated its value in this area. Several groups have reported advantages in using this technology [76, 77] . These advantages concern the quality of the data, with lower interand intra assay variation, earlier detection of the immune response since antibodies of lower kinetic stability are detected by this method, and higher information content because of kinetic profiling of the antibodies. The ability to monitor immune response quickly and directly makes this technology a valuable tool for following passive and active vaccination [78] 
Small Synthetic Drug Molecules
Experimental Considerations
When working with small synthetic drug molecules (200 Da < MW < 600 Da) one has to especially consider that the SPR response is related to the refractive index change caused by an adsorbing molecule. The refractive index change per molecule is related linearly to its molecular size, a property that limited the application of this method for a long time to the binding of larger molecules such as proteins or oligonucleotides. The study of direct binding of low molecular weight compounds to immobilized biomolecules was published first by R.Karlsson from Biacore AB in 1995 [79] . In the meantime many publications from this field appeared and monitoring the interaction of low molecular weight analytes with immobilized ligands has become an accepted application for SPR. Although sensitivity of the method has been increased during the last decades by improving mainly the optical detection system, the flow system and the data evaluation procedures, special care has still to be taken when setting up SPR-based binding assays with small molecules. Some of the most important ones will be shortly discussed in the following section. For a more comprehensive discussion the reader is referred to other publications [32, 49, 80] .
Experimental factors that critically influence the result of binding studies with small molecules are the density of active protein on the surface of an SPR device, the quality of buffers and reagents used, nonspecific binding, carry over effects and regeneration procedures. From the data evaluation side it is mainly the precise separation of signals that are due to binding from those that are due to refractive index mismatch between running buffer and analyte solution.
Density of Active Proteins
The necessity to create high densities of active target molecule on the sensor surface was already addressed in this article. The selection of the most appropriate immobilization technique and conditions is crucial for success when studying interactions between small molecules in solution and immobilized target molecule. Possibilities to increase this density and to maintain protein activity during immobilization have been discussed in chapter 4.
Quality of Cosolvents, Solubility and Quality of Tested Compounds
DMSO is often present as a cosolvent in analyte solutions because they are derived from pharmaceutical compound depositories that frequently contain highly concentrated DMSO solution. Often, DMSO is also added as a cosolvent to enhance solubility. The use of the best quality DMSO available is highly recommended.
Testing chemical purity of analyte is a must to get reliable binding data from biophysical assays. Aside from this, interference due to low solubility and non monomeric states of the analyte are probably the major causes for failure of SPR biosensor analysis. It is known that optimization of hit or lead compounds often goes along with higher hydrophobicity of the compounds, which then become more susceptible to aggregation and precipitation in aqueous solutions [81] . Such analyte assembly can influence in many different ways the outcome of the binding study. Precipitates can plug the flow channels of the miniaturized flow system and disturb continuous laminar flow over the surface. Precipitation causes reduction of the nominal concentration of ligand in solution and therefore influences kinetic or equilibrium analysis that are both dependent on the concentration. Precipitation of compounds can easily be tested optically by using a simple laser pointer (see Fig. 12 ). Intense scattering that can be observed by eye is caused by precipitates that enter into the light path. However, there are also compounds that form small aggregates or micelles in solution that can not be easily detected by this simple optical test. Analytical ultracentrifugation and/or light scattering experiments can be used to prove the assembly state of tested compounds in solution [34] . 
Carry Over Effects
Sticking to the walls of the fluidic system is another property of hydrophobic molecules. The process reduces the nominal concentration of a compound in solution and also influences the subsequent binding experiment due to carry over into subsequent analysis cycles.
Regeneration of Surfaces
Incompleted regeneration of surfaces influences the subsequent binding experiment. Regeneration seems to be more a problem when studying protein/small molecule interaction than when studying protein/protein interactions. Protein/ protein binding of high affinity can easily be cleaved using basic or acidic buffers of high salt concentration. This is probably due to the flat but extended binding areas involved in protein/protein interactions. Exchange of buffer in the cleft between the proteins to protonate or deprotonate amino acids that are essential for the interaction or shielding of electrostatic interactions might occur quite fast. The binding sites of small molecules are often deep or are even buried inside the proteins and the change of buffer conditions is slow and not very efficient. Harsh buffer conditions that cause partial unfolding and denaturation of the proteins are often needed to dissociate the small molecule from the protein. Long dissociation intervals under normal buffer conditions are often the only possibility to regenerate such surfaces. The dissociation processes can be significantly accelerated by raising the temperature and/or adding at high concentrations a competitive inhibitor that forms a complex with low kinetic stability.
Unspecific Binding
During the early phase of the drug discovery process (hit finding, lead selection) binding of low affinity compounds has to be confirmed. Consequently, the experiments have to be performed at high compound concentration. At these concentrations many of the compounds tend to bind unspecific to the immobilized protein or to stick to the surfaces. The false positive rate could be rather high without the implementation of powerful selectivity and specificity filters, which are a must. In fact, they are often the more powerful selection criteria then affinity or potency. Several experimental approaches to implement specificity filters in an experimental set-up have been introduced in chapter 3.2.
Correction for Bulk Refractive Index Changes
DMSO is often used as a cosolvent in aqueous buffer solutions when working with small synthetic compounds. Because of the relatively high refractive index of DMSO a small mismatch in the DMSO content of running buffer and sample solution can lead to signals that exceed by far the signals normally recorded for the binding of a small analyte to the immobilized protein. Correction for this mismatch can be accounted by measuring in parallel the signal created in a protein free reference channel by this sample solution. For a small mismatch this reference signal can normally be used directly to subtract the portion of the signal which is due to the refractive index change. If the mismatch is large one has to take into account that the signal due to a refractive index change is normally different for surfaces with and without protein loading. In these cases, the correction response from the reference channel has to be adjusted by running a calibration series [32, 49] . There are SPR instruments available (Biacore S51) where such calibration and correction are already included and performed automatically during measurements and data evaluation.
Hit Finding and Hit Characterization
In principle, a direct binding assay as offered by the SPR method would be the simplest method to perform screening for new hit structures. The advantage of such an approach would be mainly the fast development time for such assays and the fact that results clearly show whether the compounds interact with the target, providing that the assay is designed with proper referencing or if additional competition assays are performed as discussed in Chapter 3.2. In contrast, high throughput screening assays often produce a large portion of false positives. Despite the obvious advantages not many applications of the SPR technology in hit finding have been reported until today. This is certainly due to the moderate throughput. SPR based assays are only suited for studying a relative small number of compounds, although the recently introduced Biacore A100 system enables screening of up to almost 1000 compounds/24 hours against a panel of target proteins. Nevertheless, SPR assays are not suited for systematic primary screening where normally hundreds of thousands of compounds have to be screened.
HTS methods make use of highly integrated devices that can handle large numbers of 96, 384 or even 1536 well plate formats. This facilitates a highly parallel way of working when performing and monitoring biomolecular reactions. Such highly integrated formats and parallel measurements could not be realized so far using SPR detection technologies without compromising the sensitivity and the quality of the data.
The sensitivity of SPR based readout of highly integrated large array formats is only sufficiently high to monitor binding of large molecules to the surface (MW > 2kDa). Beside the Flexchip technology that is exclusively used to monitor proteins, another one has been introduced to monitor small molecule-protein interactions by a company called Graffinity. There is no instrument commercially available on the market but the company offers on a contract basis screenings for small molecular ligands. The method makes use of an inverse set-up; the small molecules are immobilized on the surface of the SPR device and are contacted with the protein solution. The technique includes a method to produce chemical micro arrays on a surface plasmon resonance device and an optical system that facilitates parallel plasmon resonance readout of the individual spots [82] . They claim that they have efficient surface chemistry tools to produce arrays with up to 9216 compounds. To test binding, the immobilized small molecules are tested in parallel by contacting them with a protein solution. A recent publication reports on the use of such a set up to screen for inhibitors of a transcription factor [83] .
Despite the limitation in throughput, there are a few applications published in the literature or presented at meetings that demonstrate the use of SPR in hit finding. For example, SPR screening has been performed with focused libraries that contain only a small fraction of the compounds available from the depositories of pharmaceutical companies. Specially designed and assembled target specific libraries and/or fragment libraries are also frequently used. The name fragment library implies that one of the selection criteria is a small molecular weight or a small number of non-hydrogen atoms to allow room for "growth" of structure during a subsequent lead optimization process. The other important selection criterion considers structural requirements; the selection is based on the results of docking experiments that make use of 3D structure information. Compounds are selected that fit best into the targeted site on the protein with respect to size and shape and with respect to hydrogen bonding and electrostatic interactions. Since one can not expect high affinity binding with these fragments, screenings are performed at high concentration (c > 100 µM) and solubility properties of the selected compounds become crucial. It has to be mentioned that such fragment screening is not exclusively restricted to the use of SPR. Other physical detection methods such as mass spectrometry, nuclear magnetic resonance and chromatographic methods are also used.
Böhm et al. [84] reported on the successful use of such physical detection methods including SPR to screen for compounds of novel structures that bind to the ATP binding site of bacterial gyrase. This fragment screening approach was chosen because random screening for inhibitors did not provide suitable hits. The protein used was a 24 kDa protein fragment from subunit B of DNA gyrase from E. coli. Structure information used during docking experiments was extracted from X-ray structure of the 24 kDa fragment complex with a substrate analogue and the known inhibitors cyclothialidin and novobiocin. Although they are very different in molecular structure they share in the inner pocket a very simple binding motif including a hydrogen donor and a hydrogen acceptor function. A total of about 300 compounds from fourteen different substance classes were selected applying the above mentioned criteria. They were tested using SPR but also other biophysical techniques such as fluorescence, nuclear magnetic resonance and size exclusion chromatography. Several new structure classes for inhibitors were identified via this route. Although the representatives of the class of indazoles were very weak binders and weak inhibitors, the subsequent chemical modification of this lead structure led to inhibitors with higher potency than the reference compound novobiocin. X-ray structure analysis of the complex of the indazoles with the 24 kDa gyrase fragment showed clearly that the binding hypothesis initially developed via the x-ray structure of the reference compounds novobiocin and cyclothialidin is fully adopted by this class of compound.
An analogous approach was chosen to find inhibitors for bacterial HPPK [34] . In this case a protein mutated in the active site was used as the reference protein to distinguish between active site binding and non active site, or unspecific binding (see chapter 3.2). The proteins were immobilized in parallel via amine coupling on the surface of the SPR sensor. A set of 250 compounds belonging to 10 different compound classes were selected by analogous criteria as in the case of gyrase. The compounds were tested at a concentration of 125 µM using a direct SPR based binding assay. A total of 15 site specific binders were found belonging to four of the ten compound classes. The affinity of the compounds covered the range 200 µM > K D > 400 nM.
In summary, the two examples above show that SPR based screening for new hits can be successful used when combined with efficient modeling that is based on high resolution structural information.
SPR based assays are more often used, however, in secondary screening where one has to deal with fewer compounds. Hit lists from HTS often contain false positives which show up during the screen because the compounds interact not with the target protein but with any other auxil-iary reagent in the assay solution. Especially in fluorescence based assays interference of the fluorescence of the tested compounds is often a cause for false positives. It is therefore important to show if the active compounds really interact with the target protein before starting a chemical program around a compound class. SPR based assays are highly suitable for such secondary screening with many different target protein classes. Only a few of the numerous applications published in this field can be discussed here.
One of the targets for which such secondary screening was performed most extensively is HIV-1 protease [85] [86] [87] [88] [89] [90] . The work on this target is probably a pioneering one in demonstrating all the different facets and opportunities of this kind of screening. The enzyme could be coupled to the SPR sensor surface by amine coupling. To reduce negative drifts of the baseline that were possibly due to auto proteolysis and peptide fragment dissociation, the immobilized protein was cross linked by shortly contacting the surface with amine coupling reagent. The work on HIV-1 protease is one of the few examples where not only binding activity but also enzymatic activity was tested to confirm that this immobilization strategy did not modify the function of the enzyme.
About 280 compounds were screened at one concentration and report points were monitored during the association and dissociation phase [88] . It has been established that report points during the association phase indicate how fast a complex is formed and hence how well a given compound fits into the binding pocket of the enzyme. In contrast, report points during the dissociation are indicative of the kinetic stability of the formed complex. A correlation of these report points with inhibition constants such as K i and IC 50 clearly demonstrated that this simple screen at one concentration contained a wealth of information about the inhibitory characteristics. Inhibitors of high, intermediate or low potency clustered in different areas of a plot on which report points taken during the association phase were plotted against report points taken during the dissociation phase. Report points during early dissociation are useful markers for specificity.
Markgren et al. [86] performed a detailed analysis of the binding kinetics for 31 known protease inhibitors. The authors demonstrated that kinetic data can be assigned to specific structural details (Fig. 13) and the information could be used for further chemical optimization of the compounds. Several inhibitors were tested against different mutant proteins [85] . Increased resistance of a given mutant against inhibitors was clearly correlated with the off-rates; reduced inhibitory activity for a given mutant correlated with an increase in the dissociation rate and therefore a decrease in kinetic stability of the complex. Additional information on inhibitory characteristics could be gained by determining thermodynamic properties that were obtained via the temperature dependence of kinetic rate constants [90] and equilibrium binding constants.
We have recently reported [34, 35] on the use of surface plasmon resonance assays for lead selection with DPP IV (dipeptidylpeptidase IV) as the target protein. Three different Fig. (13) . Structure affinity relationship using a k on /k off plot. The graph indicates clearly that increasing the size of the P1(open squares) residue does not influence the off-rate. The increase in the K D value is mainly due to an increase in the on-rate. This indicates that the recognition step is optimized by this structural change. Increasing the size of the P2 (filled squares) residues has an influence on the on-and the offrate. Please recognize that B268, B322 and B376 are nearly identical when only considering the affinity (K D ~ 10 nM). A k on /k off -plot indicates the significant differences in the kinetic behavior (The graph is reproduced by the permission of Biacore AB, Uppsala).
substance classes that were all active in an enzymatic assay were selected for lead expansion and the compounds synthesized were characterized in a binding assay based on surface plasmon resonance for the selection of clinical candidates. DPP-IV was immobilized covalently. To check for site specific binding, a reference channel was prepared by immobilizing DPP IV together with an inhibitor that binds covalently to the active serine in the binding pocket. Around 200 compounds were characterized by kinetic rate constants and equilibrium dissociation constants. The results are graphically represented in Fig. (14) . In this kon/koff plot it is interesting to note that the classes cluster in different areas. Two classes, the cyanopyrrolidone and the benzoquinolizin cluster in the area of fast on rates and mainly differ in their dissociation rate constants. For these two compound classes, therefore, the difference in affinity is mainly based on the kinetic stability of the formed complex. The third class is characterized by very slow on rates. There are compounds with even slower off rates than the candidates of nanomolar affinity in the two other classes. Nevertheless, affinity is only in the micromolar range due to an exceptionally slow on rate. In addition, this compound class did not specifically bind to the active site of the protein because it also bound to the modified reference protein with the covalently blocked active site. At a first glance this could indicate allosteric effect of the compounds that leads to inhibition. In other cases, such as for the estrogen receptor compounds described below, there was a clear tendency reported that the slow on and off rates were indicative for antagonists. In this case however it could clearly be demonstrated by analytical ultracentrifugation that the unusual kinetic behavior can be explained by the solubility problems of this compounds that form large cluster in aqueous solutions.
SPR technology was also used to characterize binding of small molecules to the ligand binding domain of human estrogen receptor [91, 92] . The assay was used to discern specific binders from non-binders. The time dependent responses during association and dissociation could be fitted to a simple 1/1 kinetic model to extract kinetic rate constants. Association rate constants for antagonists were found to be 500-fold slower than those determined for agonists. The finding indicates that the antagonists bind to a different conformation of the receptor. By using the biosensor assay, subtle differences were found in how the same compound binds to the different isoforms of the receptor An SPR based binding assays was used to evaluate binding of compounds to CD80, which is found on the surface of antigen-presenting cells and is believed to be a target for a therapy of autoimmune disease such as rheumatoid arthritis [94] . Debnam et al . examined binding properties of hit compounds in order to identify lead candidates. 259 compounds from five different chemical compound classes were examined [93] . The CD-80 binding properties of each compound were characterized by the determination of association and dissociation constants. The data were globally interpreted by presenting them in a kon/koff map. The general picture indicates again that high affinity is predominantly the result of slower dissociation constants. As in the DPP IV case discussed above, a subset of one class was identified which was separated from the other classes in a kon/koff map. This subset contains the compounds with the slowest off rates, but because of slow on-rates and the resulting lower affinity this compound class would have been disregarded on the basis of standard affinity-based assessment. SPR technology was also used during the subsequent hit and lead optimization process [93] . EC 50 values for the inhibition Fig. (14) . kon/koff-plot for DPP IV hit compounds. The compounds from different substance classes cluster in different areas of such a plot.
of the binding of CD28 to CD80 were determined. The data correlated well with those determined in parallel with time resolved fluorescence resonant energy transfer (TR-FRET) experiments. To assess selectivity, inhibitor binding was analyzed in parallel to CD80 and related proteins (human CD86 and CD28 and several CD80 proteins from other species).
Protein kinases are emerging as one of the most intensively studied classes of enzymes in pharmacological research because of their central roles in physiologically and clinically important cellular signaling. Despite this fact there are only a few examples in the literature, where small molecule interactions with kinases have been analyzed using surface plasmon resonance technology. Those studies mainly concern the mitogen-activated protein kinase p38 [95, 96] . It was believed that the immobilization of kinases is quite tricky due to the low stability of this type of proteins. Recently a methodology package was published [37] that can be taken as a guideline for immobilization conditions that preserve the binding capacity and the activity of the immobilized kinase. Nine different kinases were investigated and binding capacities in the range of 25-90 percent were obtained. Beside a normal binding assay to screen for inhibitors and for kinetic characterization an ATP competition assay was used. Sensorgrams of mixture of ATP and inhibitor were compared with sensorgrams for inhibitor and ATP alone. It was observed that with increasing ATP concentration the slow inhibitor kinetics turned into the fast ATP kinetics due to the replacement of inhibitor by ATP. For p38 it was also demonstrated that inactive (non-phosphorylated) and active (phosphorylated) protein behaved different in inhibitor and ATP binding. In conclusion, the publication really demonstrates the usefulness of SPR technology for characterizing inhibitor binding to kinases.
Early ADME Studies
The extent to which drugs bind to serum components and passively or actively adsorb to membranes for instance in the gastrointestinal tract or at the blood-brain barrier are two essential properties that must be considered when determining pharmacokinetics and activity profiling [97] . For both these properties assays based on SPR have been developed and discussed in the literature.
Plasma Protein Binding
It is widely accepted that the effect of a drug is related to the exposure of a patient to the unbound concentration of the drug in plasma rather than to total concentration. Binding of drugs to plasma proteins such as human serum albumin (HSA) and α-acid glycoprotein (α-hAGP) is one of the factors that influence this free concentration. HSA is the most abundant protein in plasma and serves as major transport protein for drugs. Traditionally binding to HSA has been examined using equilibrium dialysis or chromatographic techniques, with results reported as either percent bound and or binding constants. The two data sets are well correlated only for low affinities. At higher affinities (K D < 32 µM) the percent bound data (> 95%) fails to rank the binders [98] . Since it is mostly strong binding that will possibly have any influence on the therapeutic effect of drugs, the recognition of high binders is essential.
There are several publications that deal with the possibility of using SPR experiments for examining HSA binding of drug molecules [99] [100] [101] [102] [103] . In general HSA is immobilized on the surface of the sensor at relatively high densities (9-11 ng/mm 2 ) and the solutions of the drug molecules are passed over this surface. The sample solutions contained up to 5% DMSO. A study of the influence of DMSO content on the binding affinity has not been reported so far.
It was demonstrated by all publications that the SPR method is suitable to rank drug molecules with respect to HSA binding. Weak, medium and strong binders can be distinguished when immobilizing HSA on a sensor surface, contacting it with 80 µM drug solutions and taking the equilibrium response at this concentration as a relative measure for the affinity to HSA. Such a ranking correlates well with rankings based on data from equilibrium dialysis or chromatography. However, a differentiation between different strong binders (> 95 % protein binding) is again not possible using such a crude ranking. Such differentiation must be based on K D values determined via concentration dependent measurements.
The problems of determining such values using SPR methods have been critically discussed. In this case, some problems are intrinsic to HSA, while others are specifically due to the use of the SPR method. Solution measurements clearly indicate that most drug molecules have multiple binding sites on HSA and that such binding sites are subsequently occupied with increasing concentration. Because of this, saturation behavior and clear 1/1 stoichiometry is seldom observed. The same was observed for immobilized HSA. Bi-, multiphasic and linear isotherms were observed for many drug molecules that made the estimation of saturation levels and determination of equilibrium binding constants difficult or even impossible.
Recently a work was published that introduced a high resolution and high throughput protocol for the determination of K D values of HSA-drug interactions [104] . Using warfarin as a model compound it was demonstrated that highly accurate and reproducible data (K D = 3.7 µM) can be obtained by using this protocol. The protocol that can be scaled up for high throughput was used to determine binding data for 10 test compounds.
There are only a few articles reporting binding of drug molecules to other plasma proteins [104, 105] . Because of its acidic nature αAGP can not be immobilized by amine coupling. The protein has to be modified by thiol linkers and can then be immobilized via thiol coupling chemistry. The results published so far indicate that binding studies enable a similar ranking of compounds into low, medium and strong affinity binders as with HSA [104, 105] . Quantitative kinetic studies and K D determinations that would enable more mechanistic interpretations have also failed for AGP [105] . The reason for this failure might be the existence of several potential independent binding sides and the occurrence of ligand induced conformational changes. The studies clearly show that compounds can exhibit totally different binding behavior for the two proteins. Although HSA is a good single protein model for ADME studies, a more complete picture may therefore be gained by including AGP binding data. With a multi-channel SPR instrument these binding parame-ters could be determined in parallel. Binding behavior of drug molecules to other plasma proteins such as lipoproteins or immunoglobulins that could also be immobilized in parallel have not been studied in detail so far.
Interactions of Drugs with Liposomes
An important aspect of drug discovery and development is identifying drugs that are sufficiently soluble in the aqueous environment and yet pass through the hydrophobic intestinal mucosa into the blood stream. Several in vitro techniques exist to assess the lipophilicity of a drug to predict how well it will be adsorbed in the body. The most widely used predictor is the partition coefficient determined with aqueous buffer and n-octanol. Many researchers also work with liposomes, lipid vesicles that mimic the bilayer geometry and the ionic characteristics of the biological membrane. Immobilizing liposomes on a SPR sensor chip can improve this liposome-based in vitro system for predicting intestinal permeability. The liposomes captured on a surface can create a lipid barrier representative of the membrane of the intestinal epithelial cell. The stagnant aqueous solution adjacent to the lipid surface mimics the intestinal mucosa's unstirred layer. In addition the interaction of a drug with the lipids is measured in real time offering the possibility to characterize the process not only with respect to equilibrium but also with respect to kinetic parameters. The successful application of SPR techniques to study liposome/drug interaction has been demonstrated by several researchers [104, [106] [107] [108] . The authors illustrated how liposomes could be captured on specially chemically modified sensor chips. One of the publications could clearly classify the compounds with respect to their kinetic behavior [106] . Type I drugs are primarily negatively charged at physiological pH and rapidly dissociate from the lipid surface containing lipids with choline head groups. It is proposed that such drug molecules do not form a stable complex with the phosphatidylcholine molecules and pass freely into and out of the lipid bilayer. Type II molecules are primarily positively charged at physiological pH and display two distinct kinetic phases during association and dissociation. This finding suggests that these drugs both diffuse across and intercalate into the phospholipid bilayer. With its unique kinetic abilities SPR is the only method that could reveal this mechanism. Recently, a publication appeared that reports the outcome from experiments with liposomes of different composition [108] . Binding properties of 78 drug molecules to Avanti Blend liposomes and POPC liposomes were investigated. The parallel use of two types of liposomes resolved the basic from the acidic and neutral compounds, i.e. the basic compounds bound less to POPC than to the negatively charged Avanti Blend liposomes, whereas acidic and neutral drugs showed higher responses towards POPC than to the Avanti Blend. The twodimensional biosensor data correlated well with the fraction adsorbed classification. It was possible to divide the compounds into groups of high, medium and low level of adsorption.
CLOSING REMARKS
Over the last two decades SPR based assays have become an accepted method for the characterization of bio-molecular interactions. The method is today used as a biophysical tool nearly in any field of the drug discovery process. There is still room for improving this technology that could lead to even broader application.
Significant increase in through-put, for instance, will be a necessary prerequisite if the technology should be more applied in the early phase of the drug discovery process for hit finding and validation. For large biomolecules such as antibodies a break trough in this respect was the launch of the so called Flexchip technology by Biacore AB that allows massively parallel monitoring of binding events. The same company has also launched a system with higher through put that allows detection of up to 800 binding reactions of small molecular weight analytes per day. The future will show if SPR will be the physical read out technique to combine high sensitivity with very high through-put.
A field to be exploited is the monitoring of interactions of analytes with immobilized GPCR receptors. For a real breakthrough, improvements have to be achieved in several fields such as a more efficient expression and purification of the GPCR's, a more efficient and reproducible reconstitution of the GPCR's on the surface of SPR sensors and for the monitoring of small analytes even an increase in sensitivity, because one can expect that the density of active GPCR's on the surface will be much less when compared to the density that can be obtained with soluble proteins.
ACKNOWLEDGEMENT
We would like to thank Prof. Helena Danielson (Uppsala University), Garry Franklin and Markku Hämäläinen (Biacore AB, Uppsala) for critically reviewing the paper and for putting Fig. (10) to our disposal. Many thanks also to Prof. Salvatore Guccione (Catania University) and Daniel Schlatter (F. Hoffmann-La Roche AG) for reading the review and helpful discussions. 
